• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶RNA作为乳腺癌患者血清中的检测标志物。

Telomerase RNA as a detection marker in the serum of breast cancer patients.

作者信息

Chen X Q, Bonnefoi H, Pelte M F, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy H E, Meyer P, Stroun M, Anker P

机构信息

Faculté des Sciences, Pavilion des Isotopes, Geneva, Switzerland.

出版信息

Clin Cancer Res. 2000 Oct;6(10):3823-6.

PMID:11051224
Abstract

Tumor-derived circulating DNA has been found in the plasma of cancer patients. Alterations include decreased strand stability, mutations of oncogenes or of tumor suppressor genes, microsatellite alterations, and hypermethylation of several genes. RNA has also been found circulating in the plasma of normal subjects and cancer patients. Tyrosinase mRNA has been extracted from the serum of melanoma patients and subjected to RT-PCR. Moreover, the presence of cell-free EBV-associated RNA has been reported in the plasma of patients with nasopharyngeal carcinoma. Human telomerase comprises two RNA subunits, telomerase RNA template (hTR) and its catalytic component, telomerase reverse transcriptase protein (hTERT). Expression of these subunits correlates with telomerase activity. Using RT-PCR, we investigated whether these RNA subunits were present in the serum of 18 patients with breast cancer, 2 patients with benign breast disease, and 21 normal subjects. The presence of amplifiable RNA was confirmed in all tissue and serum samples using RT-PCR of glyceraldehyde-3-phosphate dehydrogenase RNA. hTR was found in 17 of 18 tumors (94%) and 5 of 18 serum samples (28%). hTERT was also detected in 17 of 18 tumors (94%) and in 4 of 16 available serum samples (25%). hTR and hTERT were undetectable in tissues and sera taken from 2 patients with benign disease and in the sera of 21 normal subjects. We conclude that RNA is detectable in the serum of breast cancer patients and that tumor-derived mRNA can be extracted and amplified using RT-PCR, even in patients with localized disease. This may have implications for cancer diagnosis and follow-up in the future.

摘要

肿瘤来源的循环DNA已在癌症患者的血浆中被发现。改变包括链稳定性降低、癌基因或肿瘤抑制基因的突变、微卫星改变以及多个基因的高甲基化。RNA也已在正常受试者和癌症患者的血浆中被发现循环存在。酪氨酸酶mRNA已从黑色素瘤患者的血清中提取并进行逆转录聚合酶链反应(RT-PCR)。此外,在鼻咽癌患者的血浆中已报道存在无细胞的EB病毒相关RNA。人端粒酶由两个RNA亚基组成,端粒酶RNA模板(hTR)及其催化成分,端粒酶逆转录酶蛋白(hTERT)。这些亚基的表达与端粒酶活性相关。我们使用RT-PCR研究了这两个RNA亚基是否存在于18例乳腺癌患者、2例乳腺良性疾病患者和21例正常受试者的血清中。通过甘油醛-3-磷酸脱氢酶RNA的RT-PCR在所有组织和血清样本中证实了可扩增RNA的存在。在18个肿瘤中的17个(94%)和18个血清样本中的5个(28%)中发现了hTR。在18个肿瘤中的17个(94%)以及16个可用血清样本中的4个(25%)中也检测到了hTERT。在2例良性疾病患者的组织和血清以及21例正常受试者的血清中未检测到hTR和hTERT。我们得出结论,乳腺癌患者的血清中可检测到RNA,并且即使是局限性疾病患者,肿瘤来源的mRNA也可通过RT-PCR提取和扩增。这可能对未来的癌症诊断和随访具有重要意义。

相似文献

1
Telomerase RNA as a detection marker in the serum of breast cancer patients.端粒酶RNA作为乳腺癌患者血清中的检测标志物。
Clin Cancer Res. 2000 Oct;6(10):3823-6.
2
Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.乳腺癌、恶性黑色素瘤或甲状腺癌患者血浆中端粒酶RNA的检测。
Oncol Rep. 2004 Jan;11(1):245-52.
3
Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.端粒酶作为乳腺癌的预后标志物:hTERT和hTR的高通量组织微阵列分析
J Pathol. 2002 Oct;198(2):181-9. doi: 10.1002/path.1191.
4
A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.膀胱癌患者尿人端粒酶逆转录酶mRNA诊断及潜在预后效用的前瞻性评估
Can J Urol. 2004 Dec;11(6):2438-44.
5
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.人端粒酶逆转录酶mRNA和人端粒酶RNA组分mRNA表达作为膀胱癌临床病理参数标志物的实时定量分析
Int J Urol. 2006 Apr;13(4):401-8. doi: 10.1111/j.1442-2042.2006.01300.x.
6
Telomerase in (pre)neoplastic cervical disease.(癌前)宫颈疾病中的端粒酶
Hum Pathol. 2000 Oct;31(10):1304-12. doi: 10.1053/hupa.2000.19299.
7
Expression of telomerase genes in thyroid carcinoma.端粒酶基因在甲状腺癌中的表达。
Int J Oncol. 2002 Aug;21(2):265-72.
8
Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.定量评估胰液样本中端粒酶活性及人端粒酶逆转录酶信使核糖核酸水平以诊断胰腺癌。
Clin Cancer Res. 2005 Mar 15;11(6):2285-92. doi: 10.1158/1078-0432.CCR-04-1581.
9
Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.人端粒酶逆转录酶在正常和恶性肾组织中的表达与端粒酶活性无关。
Clin Cancer Res. 2000 Dec;6(12):4803-9.
10
Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.端粒酶亚基人端粒酶逆转录酶在结直肠癌患者肿瘤组织和非肿瘤黏膜中的预后潜力
Cancer. 2002 Nov 15;95(10):2103-11. doi: 10.1002/cncr.10939.

引用本文的文献

1
Decoding bioactive signals of the RNA secretome: the cell-free messenger RNA catalogue.解码 RNA 分泌组的生物活性信号:无细胞信使 RNA 目录。
Expert Rev Mol Med. 2024 Apr 29;26:e12. doi: 10.1017/erm.2024.12.
2
Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment.循环游离核酸用于癌症基因分型和肿瘤微环境免疫表型分析的综合研究
Front Genet. 2023 Apr 6;14:1138625. doi: 10.3389/fgene.2023.1138625. eCollection 2023.
3
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.
cfRNA 用于疾病检测和监测的临床效用:非小细胞肺癌的概念验证研究。
Thorac Cancer. 2022 Aug;13(15):2180-2191. doi: 10.1111/1759-7714.14540. Epub 2022 Jun 16.
4
Comparison of the Fetal Fraction of Cell-Free DNA in In-Vitro Fertilization (IVF) Versus Natural Conception Evaluation of the Fetal Fraction With IVF Parameters.体外受精(IVF)与自然受孕中游离DNA胎儿分数的比较:基于IVF参数对胎儿分数的评估
Cureus. 2022 Apr 26;14(4):e24516. doi: 10.7759/cureus.24516. eCollection 2022 Apr.
5
Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related.hTERT mRNA联合甲胎蛋白、甲胎蛋白异质体L3%、异常凝血酶原对HBV或HCV相关肝硬化患者肝细胞癌的诊断价值
Cancer Inform. 2022 May 20;21:11769351221100730. doi: 10.1177/11769351221100730. eCollection 2022.
6
The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study.血浆游离循环信使 RNA 作为神经胶质瘤生物标志物的效用:一项初步研究。
Acta Neurochir (Wien). 2022 Mar;164(3):723-735. doi: 10.1007/s00701-021-05014-8. Epub 2021 Oct 13.
7
Is There a Balance in Oxidative-Antioxidant Status in Blood Serum of Patients with Advanced Endometriosis?晚期子宫内膜异位症患者血清氧化-抗氧化状态是否存在平衡?
Antioxidants (Basel). 2021 Jul 8;10(7):1097. doi: 10.3390/antiox10071097.
8
RNA packaging into extracellular vesicles: An orchestra of RNA-binding proteins?RNA 包装到细胞外囊泡中:RNA 结合蛋白的交响乐?
J Extracell Vesicles. 2020 Dec;10(2):e12043. doi: 10.1002/jev2.12043. Epub 2020 Dec 28.
9
Detection of splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies.在接受靶向治疗失败的黑色素瘤患者的血浆来源游离核酸和细胞外囊泡中检测剪接变体
Oncotarget. 2020 Nov 3;11(44):4016-4027. doi: 10.18632/oncotarget.27790.
10
Profiling the circulating mRNA transcriptome in human liver disease.分析人类肝脏疾病中的循环mRNA转录组。
Oncotarget. 2020 Jun 9;11(23):2216-2232. doi: 10.18632/oncotarget.27617.